Published in N Engl J Med on August 08, 1985
Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science (1983) 9.41
The effect of deprenyl (selegiline) on the natural history of Parkinson's disease. Science (1989) 7.03
Parkinson disease in twins: an etiologic study. JAMA (1999) 5.45
The role of radiotracer imaging in Parkinson disease. Neurology (2005) 3.02
Phenotypic variation in a large Swedish pedigree due to SNCA duplication and triplication. Neurology (2007) 2.72
Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases. Neurology (1985) 2.58
The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern Med (1987) 2.58
Lewy bodies and parkinsonism in families with parkin mutations. Ann Neurol (2001) 2.50
Aetiology of Parkinson's disease. Lancet (1984) 2.32
Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol (1999) 2.26
Granulocytic sarcoma in childhood leukemia: imaging features. Radiology (1994) 2.26
Smoking and Parkinson's disease in twins. Neurology (2002) 2.15
The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging (1999) 2.11
Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) N Engl J Med (1992) 2.01
Sequencing and analysis of the prolate-headed lactococcal bacteriophage c2 genome and identification of the structural genes. Appl Environ Microbiol (1995) 1.95
Evaluating measures of family history of alcoholism: density versus dichotomy. Addiction (1998) 1.94
Low-grade astrocytoma: a decade of experience at St. Jude Children's Research Hospital. J Clin Oncol (1997) 1.94
Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology (2011) 1.90
Factors predicting readmission of older general medicine patients. J Gen Intern Med (1992) 1.88
The hypothalamus in Parkinson disease. Ann Neurol (1978) 1.74
Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res (1984) 1.71
Novel observations with FDOPA-PET imaging after early nigrostriatal damage. Mov Disord (2001) 1.68
Selegiline and mortality in Parkinson's disease. Ann Neurol (1996) 1.67
Adjustment of a group of Vietnamese people to the United States. Am J Psychiatry (1979) 1.66
Suicide risk assessment: a review of risk factors for suicide in 100 patients who made severe suicide attempts. Evaluation of suicide risk in a time of managed care. Psychosomatics (1999) 1.65
Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology (1992) 1.62
Health care utilization by older patients with coexisting dementia and depression. Am J Psychiatry (1999) 1.58
Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): implications for treatment and the pathogenesis of Parkinson's disease. Can J Neurol Sci (1984) 1.57
Grief following spontaneous abortion. Psychiatr Clin North Am (1987) 1.56
Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys. Ann Neurol (1986) 1.56
Nicotine dependence and withdrawal in alcoholic and nonalcoholic ever-smokers. J Subst Abuse Treat (1998) 1.54
Predictors of expressed partner and non-partner violence among patients in substance abuse treatment. Drug Alcohol Depend (2000) 1.53
Psychiatric diagnosis and intervention in older and younger patients in a primary care clinic: effect of a screening and diagnostic instrument. J Am Geriatr Soc (1998) 1.50
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J Neurol Neurosurg Psychiatry (2000) 1.49
A rational approach to liver transplantation for the alcoholic patient. Psychosomatics (1990) 1.47
Physical illness presenting as psychiatric disease. Arch Gen Psychiatry (1978) 1.47
Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration. Brain Res (1988) 1.44
Levodopa induces dyskinesias in normal squirrel monkeys. Ann Neurol (2001) 1.44
Parkinsonism caused by petroleum waste ingestion. Neurology (1994) 1.42
PCR analysis of platelet mtDNA: lack of specific changes in Parkinson's disease. Mov Disord (1993) 1.42
The effects of travel barriers and age on the utilization of alcoholism treatment aftercare. Am J Drug Alcohol Abuse (1995) 1.42
(+/-)3,4-Methylenedioxymethamphetamine selectively damages central serotonergic neurons in nonhuman primates. JAMA (1988) 1.41
Correlates of expressed and received violence across relationship types among men and women substance abusers. Psychol Addict Behav (2001) 1.40
Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N Engl J Med (1983) 1.40
Aberrant response to diazepam: a new syndrome. Am J Psychiatry (1972) 1.40
Content of sodium and potassium in supraspinatus muscle from hypovitaminotic A Holstein calves. J Dairy Sci (1969) 1.40
Presentation of the steroid psychoses. J Nerv Ment Dis (1979) 1.39
Tremor in MPTP-induced parkinsonism. Neurology (1992) 1.39
Concurrent treatment of patients with depression in the community: provider practices, attitudes, and barriers to collaboration. J Fam Pract (1999) 1.39
Selegiline and Parkinson's disease: it's déjà vu-again. Neurology (2000) 1.37
Failure of operative cholangiography to prevent retained common duct stones. Am J Surg (1973) 1.34
Symptoms and correlates of anabolic-androgenic steroid dependence. Br J Addict (1991) 1.33
Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging (2000) 1.31
Corynebacterium mooreparkense sp. nov. and Corynebacterium casei sp. nov., isolated from the surface of a smear-ripened cheese. Int J Syst Evol Microbiol (2001) 1.26
Similarities and differences between MPTP-induced parkinsonsim and Parkinson's disease. Neuropathologic considerations. Adv Neurol (1993) 1.25
Unrecognized physical illness prompting psychiatric admission: a prospective study. Am J Psychiatry (1981) 1.25
1-Methyl-4-phenylpyridinium ion (MPP+): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci Lett (1984) 1.24
Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization. J Comp Neurol (2000) 1.24
Pargyline prevents MPTP-induced parkinsonism in primates. Science (1984) 1.22
Liver transplantation for alcoholic liver disease: a survey of transplantation programs in the United States. Liver Transpl Surg (1997) 1.22
Angel's Trumpet psychosis: a central nervous system anticholinergic syndrome. Am J Psychiatry (1977) 1.21
MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects. Acta Neurol Scand Suppl (1984) 1.20
The CRABEL score--a method for auditing medical records. Ann R Coll Surg Engl (2001) 1.19
Essential tremor in twins: an assessment of genetic vs environmental determinants of etiology. Neurology (2001) 1.19
Alcohol use after liver transplantation in alcoholics: a clinical cohort follow-up study. Hepatology (1997) 1.16
MPTP: current concepts and controversies. Clin Neuropharmacol (1986) 1.16
Permanent neurological deficits due to lithium toxicity. Ann Neurol (1983) 1.16
Psychiatric effects of thyroid hormone disturbance. Psychosomatics (1983) 1.14
Positron emission tomography after MPTP: observations relating to the cause of Parkinson's disease. Nature (1985) 1.14
Physical illness manifesting as psychiatric disease. II. Analysis of a state hospital inpatient population. Arch Gen Psychiatry (1980) 1.13
An evaluation of 99mTc-labeled hepatobiliary agents. J Nucl Med (1977) 1.13
Diffusion tensor imaging of tract involvement in children with pontine tumors. AJNR Am J Neuroradiol (2006) 1.12
Prediction of in-hospital cardiopulmonary arrest outcome. Arch Intern Med (1989) 1.11
Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration. Neuroscience (2006) 1.11
Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions. Ann Neurol (1994) 1.11
Screening for alcoholism among medical inpatients: how important is corroboration of patient self-report? Alcohol Clin Exp Res (1998) 1.10
Astrocytes and Parkinson's disease. Prog Brain Res (1992) 1.09
The effect of desmethylimipramine on the absorption of alcohol and paracetamol. Postgrad Med J (1976) 1.09
Low-grade astrocytoma with neuraxis dissemination at diagnosis. J Neurosurg (1995) 1.09
Correlates of violence history among injured patients in an urban emergency department: gender, substance use, and depression. J Addict Dis (2007) 1.08
Abnormalities of the central nervous system in very young children with sickle cell anemia. J Pediatr (1998) 1.08
Rapid ATP loss caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse brain. J Neurochem (1991) 1.08
Occupation and parkinsonism in three movement disorders clinics. Neurology (2005) 1.08
Alcohol abuse/dependence in motor vehicle crash victims presenting to the emergency department. Acad Emerg Med (1997) 1.08
Stability in the drinking habits of older problem-drinkers recruited from nontreatment settings. J Subst Abuse Treat (2000) 1.07
Adsorption of bovine serum albumin onto hydroxyapatite. Biomaterials (1995) 1.07
Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism. Lancet (1990) 1.07
Interdisciplinary geriatric primary care evaluation and management: two-year outcomes. J Am Geriatr Soc (2000) 1.06
Connective tissue elements as diagnostic aids in periodontology. Periodontol 2000 (2000) 1.06
Cognitive change following MPTP exposure. Neurology (1990) 1.05
Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs. J Physiol (1971) 1.05
Long-term follow-up of patients with alcoholic liver disease who underwent hepatic transplantation. Liver Transpl Surg (1997) 1.04
Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc Natl Acad Sci U S A (1992) 1.04
The effect of aspirin on the response to endotoxin. Aust J Exp Biol Med Sci (1972) 1.03
High risk of recurrent stroke after discontinuance of five to twelve years of transfusion therapy in patients with sickle cell disease. J Pediatr (1991) 1.03
Evidence for physical and psychological dependence on anabolic androgenic steroids in eight weight lifters. Am J Psychiatry (1990) 1.02
The modified global assessment of functioning scale: addendum. Psychosomatics (1995) 1.02
Gender differences in the development of substance-related problems: the impact of family history of alcoholism, family history of violence and childhood conduct problems. J Stud Alcohol (2000) 1.02